RenovaCare, Inc. (RCAR)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 3, 2025, 4:00 PM EST
RenovaCare Market Cap
RenovaCare has a market cap or net worth of $87 as of November 4, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
87.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 8, 2000, RenovaCare's market cap has decreased from 28.70M to 87.00, a decrease of -100.00%. That is a compound annual growth rate of -39.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 87.00 | -100.00% |
| Dec 30, 2022 | 1.76M | -92.81% |
| Dec 31, 2021 | 24.41M | -90.02% |
| Dec 31, 2020 | 244.59M | -12.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |